In today's fast-paced world, many individuals face challenges when it comes to overall vitality and well-being. These issues ...

For the average person, living at high altitude—where oxygen is sparser than at sea level—can have health benefits ranging ...

The supplement tricaprin, which is found in coconut or MCT oil, improved long-term survival for people with triglyceride ...

Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...

Built from contrasts as delightful as they are disconcerting, the new animated series from folks behind "Scavengers Reign" ...

A ~$4.5B share repurchase program adds further value. LIBTAYO demonstrated massive growth, accelerating to 50% in Q4 2024 versus Q4 2023. Approval in CSCC means that this growth catalyst is ...

In the fourth quarter of 2024, Libtayo grew sales 50% to $367 million, propelling the PD-1 treatment past the blockbuster threshold for the first time. During the full year, the drug's sales reach ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

Supply-side policy proponents argue that by targeting the economic variables that boost production, a trickle-down effect occurs as companies produce more and expand, they will employ more workers ...